ASTH COO/CFO reports 1,979-share tax-surrender; 174,967 shares retained
Rhea-AI Filing Summary
Astrana Health insider sale and equity schedule
The company's COO and CFO, Basho Chandan, reported a disposition of 1,979 shares of common stock on 10/02/2025 at a price of $27.77 per share. The filing states the shares were surrendered to satisfy tax withholding on restricted stock units that vested on that date. Following the transaction, the reporting person beneficially owns 174,967 shares, which include multiple tranches of unvested restricted stock and restricted stock units scheduled to vest between 03/05/2026 and 05/16/2027, subject to continued employment.
Positive
- Transaction was a tax-surrender of vested RSUs rather than an open-market sale, indicating administrative purpose.
- Significant retained ownership: reporting person still holds 174,967 shares, aligning management with shareholders.
- Structured vesting schedule extends through 05/16/2027, supporting retention incentives.
Negative
- Reduction in immediate economic stake via surrender of 1,979 shares on 10/02/2025.
- Concentration of future dilution as multiple RSU tranches and restricted stock vest between 03/05/2026 and 05/16/2027.
Insights
TL;DR: Insider sold a small stake to cover taxes while retaining substantial equity through unvested awards.
The filing shows a 1,979-share disposition executed to satisfy withholding on vested RSUs, which is a common administrative step and does not necessarily indicate a change in insider confidence. The reporting person remains an executive (COO and CFO) with 174,967 shares beneficially owned, including multiple scheduled vesting tranches through 05/16/2027.
Risks include concentration of executive equity tied to future continued employment and potential share overhang as awards vest. Monitor upcoming vesting dates through 2027 for dilution timing and any further open-market transactions within the next 6–18 months.
TL;DR: The transaction is recorded as a tax-surrender of vested awards, not an open-market sale for cash.
The explanation explicitly states the shares were surrendered to offset tax withholding on RSUs that vested on 10/02/2025, which typically reduces net dilution compared with a cash purchase to cover taxes. The report also lists detailed vesting for remaining restricted stock and RSUs, indicating structured retention through staggered vesting schedules beginning 03/05/2026.
From an accounting view, these actions affect share count dynamics minimally at the transaction date but create predictable future share releases; watch the effect on basic and diluted shares outstanding around each vesting milestone in 2026 and 2027.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 1,979 | $27.77 | $55K |
Footnotes (1)
- Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2025. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 19,504 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
